Repeated Amiodarone Dosing In Cardiac surgicaL Procedures

Summary

This study is a single-center, prospective, randomized, open-label trial of subjects who develop atrial fibrillation after non-emergent cardiac surgery at the University of Kentucky Chandler Medical Center (UKCMC). Patients will be randomized to receive either a conventional amiodarone dosing regimen (CDR) or a repeated amiodarone bolus dosing regimen (RBDR).

Timeline

Start

2021-11-02

Primary completion

2022-10-10

Completion

2022-10-10

Drugs

Indications